129 related articles for article (PubMed ID: 12914221)
1. [Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site].
Liu S; Pei J; Chen H; Zhu X; Liu Z; Ma W; He F; Lai L
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 May; 35 Suppl():62-5. PubMed ID: 12914221
[TBL] [Abstract][Full Text] [Related]
2. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.
Chen S; Chen L; Tan J; Chen J; Du L; Sun T; Shen J; Chen K; Jiang H; Shen X
J Biol Chem; 2005 Jan; 280(1):164-73. PubMed ID: 15507456
[TBL] [Abstract][Full Text] [Related]
3. pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses.
Tan J; Verschueren KH; Anand K; Shen J; Yang M; Xu Y; Rao Z; Bigalke J; Heisen B; Mesters JR; Chen K; Shen X; Jiang H; Hilgenfeld R
J Mol Biol; 2005 Nov; 354(1):25-40. PubMed ID: 16242152
[TBL] [Abstract][Full Text] [Related]
4. A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening.
Xiong B; Gui CS; Xu XY; Luo C; Chen J; Luo HB; Chen LL; Li GW; Sun T; Yu CY; Yue LD; Duan WH; Shen JK; Qin L; Shi TL; Li YX; Chen KX; Luo XM; Shen X; Shen JH; Jiang HL
Acta Pharmacol Sin; 2003 Jun; 24(6):497-504. PubMed ID: 12791174
[TBL] [Abstract][Full Text] [Related]
5. Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.
Li C; Qi Y; Teng X; Yang Z; Wei P; Zhang C; Tan L; Zhou L; Liu Y; Lai L
J Biol Chem; 2010 Sep; 285(36):28134-40. PubMed ID: 20489209
[TBL] [Abstract][Full Text] [Related]
6. Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure.
Hu T; Zhang Y; Li L; Wang K; Chen S; Chen J; Ding J; Jiang H; Shen X
Virology; 2009 Jun; 388(2):324-34. PubMed ID: 19409595
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
Anand K; Ziebuhr J; Wadhwani P; Mesters JR; Hilgenfeld R
Science; 2003 Jun; 300(5626):1763-7. PubMed ID: 12746549
[TBL] [Abstract][Full Text] [Related]
8. Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer.
Xu T; Ooi A; Lee HC; Wilmouth R; Liu DX; Lescar J
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Nov; 61(Pt 11):964-6. PubMed ID: 16511208
[TBL] [Abstract][Full Text] [Related]
9. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations.
Chen S; Hu T; Zhang J; Chen J; Chen K; Ding J; Jiang H; Shen X
J Biol Chem; 2008 Jan; 283(1):554-564. PubMed ID: 17977841
[TBL] [Abstract][Full Text] [Related]
10. The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis.
Ding L; Zhang XX; Wei P; Fan K; Lai L
Anal Biochem; 2005 Aug; 343(1):159-65. PubMed ID: 15935325
[TBL] [Abstract][Full Text] [Related]
11. Only one protomer is active in the dimer of SARS 3C-like proteinase.
Chen H; Wei P; Huang C; Tan L; Liu Y; Lai L
J Biol Chem; 2006 May; 281(20):13894-8. PubMed ID: 16565086
[TBL] [Abstract][Full Text] [Related]
12. SARS CoV main proteinase: The monomer-dimer equilibrium dissociation constant.
Graziano V; McGrath WJ; Yang L; Mangel WF
Biochemistry; 2006 Dec; 45(49):14632-41. PubMed ID: 17144656
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic activity of the SARS coronavirus main proteinase dimer.
Graziano V; McGrath WJ; DeGruccio AM; Dunn JJ; Mangel WF
FEBS Lett; 2006 May; 580(11):2577-83. PubMed ID: 16647061
[TBL] [Abstract][Full Text] [Related]
14. Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CL(pro) .
Barrila J; Gabelli SB; Bacha U; Amzel LM; Freire E
Biochemistry; 2010 May; 49(20):4308-17. PubMed ID: 20420403
[TBL] [Abstract][Full Text] [Related]
15. A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: implication for structure and active site binding mechanism.
Phakthanakanok K; Ratanakhanokchai K; Kyu KL; Sompornpisut P; Watts A; Pinitglang S
BMC Bioinformatics; 2009 Jan; 10 Suppl 1(Suppl 1):S48. PubMed ID: 19208150
[TBL] [Abstract][Full Text] [Related]
16. Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease.
Wu CG; Cheng SC; Chen SC; Li JY; Fang YH; Chen YH; Chou CY
Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):747-55. PubMed ID: 23633583
[TBL] [Abstract][Full Text] [Related]
17. Long-range cooperative interactions modulate dimerization in SARS 3CLpro.
Barrila J; Bacha U; Freire E
Biochemistry; 2006 Dec; 45(50):14908-16. PubMed ID: 17154528
[TBL] [Abstract][Full Text] [Related]
18. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.
Huang C; Wei P; Fan K; Liu Y; Lai L
Biochemistry; 2004 Apr; 43(15):4568-74. PubMed ID: 15078103
[TBL] [Abstract][Full Text] [Related]
19. Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.
Lai L; Han X; Chen H; Wei P; Huang C; Liu S; Fan K; Zhou L; Liu Z; Pei J; Liu Y
Curr Pharm Des; 2006; 12(35):4555-64. PubMed ID: 17168761
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.
Tsai KC; Chen SY; Liang PH; Lu IL; Mahindroo N; Hsieh HP; Chao YS; Liu L; Liu D; Lien W; Lin TH; Wu SY
J Med Chem; 2006 Jun; 49(12):3485-95. PubMed ID: 16759091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
